Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-regurgitation study

Aaron S. Long, Joshua Finer, Heidi Hartman, Dustin N. Hartzel, Linyuan Jing, Chris R. Kelsey, Daniel Rocha, Jeffrey Ruhl, David P. vanMaanen, Youssef Elnabawi,

European Heart Journal · 2025 · 19 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND AND AIMS: Classification and risk stratification in aortic (AR), mitral (MR), and tricuspid regurgitation (TR) remains a significant clinical challenge. This study aimed to develop an artificial intelligence (AI) system to assess valvular regurgitation and stratify MR-progression risk. METHODS: Using transthoracic echocardiograms (TTEs) at two sites (internal development/test, external test), the DELINEATE-Regurgitation system was developed to classify AR, MR, and TR severity using colour Doppler videos. Methods of summating video-level classifications into study-level predictions were tested, comparing single-view with multiview approaches integrating predictions across multiple videos. Model agreement with cardiologists was assessed by weighted kappa. A separate AI system (DELINEATE-MR-Progression) analysing colour Doppler videos was developed to predict which patients with mild, mild-moderate, and moderate MR were most likely to progress to moderate-severe or severe MR with analysis by Kaplan-Meier and Cox proportional hazards models. RESULTS: A total of 71 660 TTEs with 1 203 980 colour Doppler videos were included. The weighted kappa in internal/external test sets for regurgitation classification was 0.81/0.76 for AR, 0.76/0.72 for MR, and 0.73/0.64 for TR using a multiview approach taking all colour Doppler videos in a study, demonstrating substantial agreement with cardiologist interpretation with superiority of multiview over single view approaches. In the progression analysis, the AI score stratified MR-progression risk even when controlled for clinical factors known to be associated with MR progression [internal test set hazard ratio 4.1 (95% confidence interval 2.5-6.6)]. CONCLUSIONS: An AI system can accurately classify AR, MR, and TR and predict MR progression beyond currently known risk factors.

References

30